RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.

Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents.

Add to Collection
2018 Others Fist_Author_Year_PM

Full Author : ['Patel, Ashish D', 'Barot, Rahul', 'Parmar, Inaxi', 'Panchal, Ishan', 'Shah, Umang', 'Patel, Mehul', 'Mishtry, Bharat']
Journal Title : Current computer-aided drug design
Chapter : Section3
Journal Year : 2018
Cited by : Not Available

BACKGROUND: 1,6-Dihydropyrimidine exerts notable pharmacological efficiency and emerged as integral backbones for treatment of type-II diabetes mellitus. To optimize the in vitro and In-silico study we carried out on substituted 1,6-Dihydropyrimidine. The.....

Keywords : ["molecular docking insilico admet study", "protein tyrosine phosphatase inhibitor", "develop antidiabetic agent", "dihydropyrimidine derivative", "development", "design", "approach"]